GlobeNewswire by notified

Scandinavian Tobacco Group A/S - Interim report, 1 January-30 September 2019

Share

 Company Announcement

No.12 2019

                                                                                                        Copenhagen,14 November 2019

Scandinavian Tobacco Group A/S - Interim report, 1 January-30 September 2019
Scandinavian Tobacco Group delivers organic EBITDA growth of 5.4% and strong cash flow in the third quarter of 2019 Q3 2019 Highlights

  • Net sales of DKK 1,846 million (DKK 1,887 million). Organic growth -4.5%
  • EBITDA before special items of DKK 446 million (DKK 398 million). Organic growth 5.4%
  • EBITDA margin before special items was 24.2% (21.1%). Excluding IFRS 16, the margin improved by 1.9% points
  • Free cash flow before acquisitions of DKK 503 million (DKK 327 million)
  • Earnings Per Share (EPS) of DKK 1.7 (DKK 2.2). EPS adjusted for special items of DKK 2.6 (DKK 2.4)
  • Agreement of the terms and conditions for the acquisition of Royal Agio Cigars

In the third quarter of 2019, Scandinavian Tobacco Group A/S delivered net sales of DKK 1,846 million and EBITDA before special items of DKK 446 million. The quarter delivered positive organic growth in EBITDA of 5.4% with EBITDA margins (excluding IFRS 16) improving by 1.9% driven by Region Smoking Tobacco & Accessories and North America Branded. Organic growth in net sales was negative by 4.5% driven by all divisions. In the first nine months of 2019, the Group reported negative organic net sales growth of 2.4% and organic EBITDA growth of 5.8%, generating a free cash flow before acquisitions of DKK 819 million (DKK 464 million) and an EPS of DKK 4.7 (DKK 5.1). EPS adjusted for special items were DKK 5.9 (DKK 5.4).

CEO of Scandinavian Tobacco Group Niels Frederiksen says: “In the third quarter of the year we deliver organic EBITDA growth of 5.4%, continued margin improvements and a strong free cash flow despite a disappointing development in organic net sales. This follows better than expected progress from our transformational program Fuelling the Growth and continued cash flow focus across our business. During the quarter we were also able to announce our intention to acquire Royal Agio Cigars; a significant step in support of our ambition to become the undisputed leader in cigars and pipe tobacco.”

Financial guidance for 2019
The full-year guidance for free cash flow is revised up and is now about 1 billion from previously >750 million. Special items are expected to be about DKK 200 million. The revised expectation includes transaction costs from the Royal Agio Cigars acquisition of about DKK 20 million, costs for the closure of Scandinavian Tobacco Group Lane Ltd.’s facility in the US of up to DKK 120 million and lower than previously anticipated costs relating to the Fuelling the Growth program. The guidance for organic growth in EBITDA is unchanged.

  • >5% organic growth in EBITDA
  • Special items of about DKK 200 million
  • Free cash flow before acquisitions about 1 billion (previous >DKK 750 million)

In the fourth quarter of 2019, we expect that the development in organic net sales will remain weak.


Conference Call and Webcast A conference call and webcast will be held on 14 November 2019 at 10:00 AM CET. Presentation materials will be available online approximately one hour before the webcast on investor.st-group.com. Dial-in details: Denmark:       +45 3272 8042 The UK:          +44 (0) 844 571 8892 The US:          +1 631 510 7495 Passcode:      3155398 https://edge.media-server.com/m mc/p/duuim98j
For further information, please contact: Investors: Torben Sand, Head of Investor Relations, phone: +45 5084 7222 or torben.sand@st-group.com Media: Simon Mehl Augustesen, Director of Group Communications, phone: +45 5084 7211 or simon.augustesen@st-group.com

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Magna Announces 2024 Annual Meeting Results10.5.2024 00:00:00 CEST | Press release

AURORA, Ontario, May 09, 2024 (GLOBE NEWSWIRE) -- Magna International Inc. (TSX: MG; NYSE: MGA) today announced voting results from its 2024 annual meeting of shareholders held on May 9, 2024. A total of 230,328,916 Common Shares or 80.18% of our issued and outstanding Common Shares were represented in person or by proxy at the meeting. Shareholders voted in favour of each item of business, as follows: a. Election of Directors Nominee Votes FORNomineeVotes FORMary S. Chan95.27%Mary Lou Maher98.16%Hon. V. Peter Harder98.97%William A. Ruh96.46%Jan R. Hauser99.73%Dr. Indira V. Samarasekera89.07%Seetarama S. Kotagiri (CEO)99.54%Matthew Tsien96.22%Jay K. Kunkel99.83%Dr. Thomas Weber95.08%Robert F. MacLellan97.63%Lisa S. Westlake95.29% b. Other Items of Business Item Votes FORReappointment of Deloitte99.65%Say on Pay85.36% Based on the voting results, all 12 nominees were re-elected to the Board, Deloitte was reappointed as independent auditor, and the “Say on Pay” resolution was approved –

Baltic Horizon Fund Consolidated Unaudited Results for Q1 20249.5.2024 22:55:00 CEST | Press release

Management Board of Northern Horizon Capital AS has approved the unaudited financial results of Baltic Horizon Fund (the Fund) for the three months of 2024. Our strategic ambitions Over the past year, our focus has been on reshaping our strategy to foster sustainable value, concentrating efforts on avenues that promise reliable and consistent growth for our investors. In light of prevailing market conditions, we firmly believe that the execution of the ‘Modern City Life’ strategy, introduced to investors in summer 2023, is paramount to their best interests. In the coming years, we expect two thirds of the Fund’s NOI to come from centrally located multi-functional assets aligned with our ‘Modern City Life’ strategy. These spaces are meticulously designed to ignite, elevate and enrich the lives of modern citizens and communities. The remaining results are expected to be derived primarily from government-rented premises and select suburban supermarkets and other segments. Our value propos

DBV Technologies to Participate in Upcoming Investor Conferences9.5.2024 22:30:00 CEST | Press release

Montrouge, France, May 9, 2024 DBV Technologies to Participate in Upcoming Investor Conferences DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company focused on treatment options for food allergies and other immunologic conditions with significant unmet medical need, today announced Daniel Tassé, Chief Executive Officer, will deliver a company presentation at two investor conferences in May. Citizens JMP Life Sciences Conference – May 13, 2024 Format: Fireside Chat Time: 11:00am ET Location: Hilton Midtown Hotel, New York, NY H.C. Wainwright BioConnect Conference – May 20, 2024 Format: Fireside Chat Time: 12:00pm ET Location: NASDAQ World Headquarters, New York, NY A live webcast of each presentation will be available on the Events page on the Investors section of the Company's website www.dbv-technologies.com. A replay will also be available for 90 days after each event. About DBV Technologies DBV Technologies is

King Faisal Specialist Hospital & Research Centre Leading Health Sector Transformation in Saudi Arabia9.5.2024 17:06:04 CEST | Press release

RIYADH, Saudi Arabia, May 09, 2024 (GLOBE NEWSWIRE) -- Harvard University -- Eight years into Vision 2030, Saudi Arabia has made significant strides with digital innovations and enhanced access to quality care. Strategic investments in infrastructure, technology, and talent, have led to advancements revolutionizing patient care delivery and elevating the standards of healthcare locally. These efforts have notably raised the average life expectancy, reduced mortality rates, and enhanced overall well-being across the Kingdom. Central to these achievements, King Faisal Specialist Hospital & Research Centre (KFSH&RC), renowned for its specialized care and treatments across critical fields such as oncology, cardiology, organ transplantation, and genetics has positioned itself as a leader in specialized patient care, taking the charge towards a brighter, healthier future for the Kingdom. Through its commitment to pioneering digital health initiatives, comprehensive educational programs, and

Corza Medical Named “Best Overall MedTech Company” in 8th Annual MedTech Breakthrough Awards Program9.5.2024 16:30:00 CEST | Press release

Prestigious International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Products and Companies WESTWOOD, Mass., May 09, 2024 (GLOBE NEWSWIRE) -- Corza Medical today announced that it has been selected as the winner of the “Best Overall MedTech Company” award in the 8th annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies, and products in the global digital health and medical technology market. Corza Medical provides healthcare professionals with a platform of surgical technologies and features industry-leading brands. The company partners closely with clinicians and surgical providers to create a differentiated surgical experience through remarkable products and services that save time, money, and effort. Working with diverse healthcare providers ranging from hospital administrators to private practices, this exceptional medical device

HiddenA line styled icon from Orion Icon Library.Eye